Published in Neuropharmacology on July 13, 2012
Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev (2014) 1.37
Neurosystems: brain rhythms and cognitive processing. Eur J Neurosci (2013) 1.13
The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol Biochem Behav (2013) 1.11
The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry (2015) 0.94
Pharmacological enhancement of memory or cognition in normal subjects. Front Syst Neurosci (2014) 0.87
Boosting visual cortex function and plasticity with acetylcholine to enhance visual perception. Front Syst Neurosci (2014) 0.85
Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. J Cogn Neurosci (2014) 0.83
Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications. J Neuroendocrinol (2016) 0.83
Effects of sustained proNGF blockade on attentional capacities in aged rats with compromised cholinergic system. Neuroscience (2013) 0.80
Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Biochem Pharmacol (2013) 0.79
Neuronal effects of nicotine during auditory selective attention. Psychopharmacology (Berl) (2014) 0.78
Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2014) 0.78
Neurobiological Impact of Nicotinic Acetylcholine Receptor Agonists: An Activation Likelihood Estimation Meta-Analysis of Pharmacologic Neuroimaging Studies. Biol Psychiatry (2015) 0.78
The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages. Pharmacol Biochem Behav (2013) 0.78
Recent theoretical, neural, and clinical advances in sustained attention research. Ann N Y Acad Sci (2017) 0.76
Method for Testing Sustained Attention in Touchscreen Operant Chambers in Rats. J Neurosci Methods (2016) 0.75
An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function. Curr Neuropharmacol (2014) 0.75
Commentary: Visual Feedback of Tongue Movement for Novel Speech Sound Learning. Front Hum Neurosci (2016) 0.75
Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking. Front Hum Neurosci (2017) 0.75
The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach. Clin Psychopharmacol Neurosci (2015) 0.75
Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci (2002) 33.22
A feature-integration theory of attention. Cogn Psychol (1980) 16.69
Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci (2000) 11.10
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
A default mode of brain function: a brief history of an evolving idea. Neuroimage (2007) 8.85
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology (1998) 8.73
Mechanisms of visual attention in the human cortex. Annu Rev Neurosci (2000) 8.50
Attention and the detection of signals. J Exp Psychol (1980) 7.51
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology (1998) 7.27
From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol (1980) 5.46
International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev (1998) 5.34
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia (1997) 5.31
Function of the thalamic reticular complex: the searchlight hypothesis. Proc Natl Acad Sci U S A (1984) 3.93
Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron (2007) 3.79
Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev (2005) 3.24
Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry (2008) 3.13
Attention modulates responses in the human lateral geniculate nucleus. Nat Neurosci (2002) 3.07
Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull (2007) 2.94
Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology (2010) 2.74
Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci (1991) 2.73
Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol (1996) 2.71
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology (2000) 2.64
Coordination of voluntary and stimulus-driven attentional control in human cortex. Psychol Sci (2005) 2.57
The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Brain Res Rev (2001) 2.56
Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci (2001) 2.54
More attention must be paid: the neurobiology of attentional effort. Brain Res Rev (2006) 2.51
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci (2009) 2.38
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci (2003) 2.35
Neuroimaging studies of attention: from modulation of sensory processing to top-down control. J Neurosci (2003) 2.28
Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science (2000) 2.28
Attentional modulation of thalamic reticular neurons. J Neurosci (2006) 2.16
M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron (2006) 2.07
Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature (1996) 2.06
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry (1989) 1.94
Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A (2001) 1.87
Nicotinic receptor subtypes and cognitive function. J Neurobiol (2002) 1.86
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Prefrontal projections to the thalamic reticular nucleus form a unique circuit for attentional mechanisms. J Neurosci (2006) 1.80
Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci (1996) 1.80
Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) (1984) 1.79
Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (1996) 1.75
Cognitive mechanisms of nicotine on visual attention. Neuron (2002) 1.71
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity. Mol Pharmacol (2008) 1.68
Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci (2001) 1.65
Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci (2007) 1.61
Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull (1996) 1.58
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. J Neurosci (2009) 1.57
Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J Neurosci (2000) 1.56
Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann N Y Acad Sci (2008) 1.52
Therapeutic opportunities for muscarinic receptors in the central nervous system. J Med Chem (2000) 1.52
Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) (1995) 1.51
Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology (2004) 1.46
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol (2007) 1.46
Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41
Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry (2007) 1.39
Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology (2005) 1.39
Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res (2000) 1.39
Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci (2000) 1.39
Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine. Psychopharmacology (Berl) (1977) 1.35
Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex (2005) 1.34
The basal forebrain corticopetal system revisited. Ann N Y Acad Sci (1999) 1.34
Increases in cortical acetylcholine release during sustained attention performance in rats. Brain Res Cogn Brain Res (2000) 1.34
Rats and humans paying attention: cross-species task development for translational research. Neuropsychology (2008) 1.32
AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci (1994) 1.31
Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology (2010) 1.31
Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback. Mol Neurobiol (2007) 1.31
Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci (2004) 1.30
Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention. Science (2011) 1.28
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology (2007) 1.27
Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience (2002) 1.26
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res Brain Res Rev (1993) 1.25
Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron (2004) 1.25
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci (2008) 1.25
The modular organization of brain systems. Basal forebrain: the last frontier. Prog Brain Res (2002) 1.24
Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J Neurosci (2011) 1.24
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry (2006) 1.24
Attentional effects of nicotinic agonists in rats. Neuropharmacology (2003) 1.24
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl) (1992) 1.22
Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex. Neuroscience (2005) 1.22
The nucleus accumbens: a switchboard for goal-directed behaviors. PLoS One (2009) 1.22
Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J Neurosci (2010) 1.20
Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berl) (1998) 1.20
Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage (2010) 1.20
The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci (2010) 1.19
Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacologia (1975) 1.19
Electrophysiological evidence for the existence of a posterior cortical-prefrontal-basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas. Neuroscience (2003) 1.18
Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol (2007) 1.17
Cognitive control in adolescence: neural underpinnings and relation to self-report behaviors. PLoS One (2011) 1.14
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci (2010) 1.14
Attention: oscillations and neuropharmacology. Eur J Neurosci (2009) 1.13
nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. Biochem Pharmacol (2009) 1.13
The modulatory effects of nicotine on parietal cortex activity in a cued target detection task depend on cue reliability. Neuroscience (2005) 1.13
Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neural Biol (1986) 1.13
Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology (Berl) (1999) 1.12
Modelling dementia: effects of scopolamine on memory and attention. Neuropsychologia (1988) 1.11
Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex (2012) 1.11
Cortical input to the basal forebrain. Neuroscience (1997) 1.11
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Arch Gen Psychiatry (1987) 1.10
Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl) (2000) 1.09
Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron (2007) 3.79
Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology (2010) 2.74
Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann N Y Acad Sci (2008) 1.52
Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology (2008) 1.36
Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex (2005) 1.34
Rats and humans paying attention: cross-species task development for translational research. Neuropsychology (2008) 1.32
Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology (2010) 1.31
Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci (2004) 1.30
Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol (2007) 1.28
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci (2008) 1.25
Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J Neurosci (2011) 1.24
Cholinergic control over attention in rats prone to attribute incentive salience to reward cues. J Neurosci (2013) 1.22
CNTRICS final task selection: control of attention. Schizophr Bull (2009) 1.21
Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J Neurosci (2010) 1.20
Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage (2010) 1.20
Ascending visceral regulation of cortical affective information processing. Eur J Neurosci (2003) 1.10
Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans. J Neurosci (2013) 1.08
Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology (2007) 1.07
Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J Neurosci (2005) 1.02
Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP). Behav Brain Res (2011) 1.01
The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. J Neurosci (2013) 1.00
Cholinergic optimization of cue-evoked parietal activity during challenged attentional performance. Eur J Neurosci (2009) 1.00
Interactions between cognition and circadian rhythms: attentional demands modify circadian entrainment. Behav Neurosci (2009) 1.00
NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. Eur J Neurosci (2005) 0.98
Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task. Schizophr Res (2013) 0.96
CNTRICS final biomarker selection: Control of attention. Schizophr Bull (2011) 0.96
Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release. Synapse (2007) 0.94
Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl) (2002) 0.93
Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats. Psychopharmacology (Berl) (2002) 0.91
Increases in cholinergic neurotransmission measured by using choline-sensitive microelectrodes: enhanced detection by hydrolysis of acetylcholine on recording sites? Neurochem Int (2008) 0.91
Bidirectional interactions between circadian entrainment and cognitive performance. Learn Mem (2012) 0.90
Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist. Neuropsychopharmacology (2012) 0.89
Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Neuropsychopharmacology (2007) 0.89
D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology (2007) 0.89
Lateralized attentional functions of cortical cholinergic inputs. Behav Neurosci (2004) 0.87
Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment. Neuropsychopharmacology (2009) 0.87
Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging. Eur J Neurosci (2012) 0.87
Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. J Neurosci (2013) 0.86
Interactions between aging and cortical cholinergic deafferentation on attention. Neurobiol Aging (2002) 0.85
Time to pay attention: attentional performance time-stamped prefrontal cholinergic activation, diurnality, and performance. J Neurosci (2012) 0.85
Microdialysis without acetylcholinesterase inhibition reveals an age-related attenuation in stimulated cortical acetylcholine release. Neurobiol Aging (2003) 0.85
Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiatry (2005) 0.84
Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. J Cogn Neurosci (2014) 0.83
Cognitive performance as a zeitgeber: cognitive oscillators and cholinergic modulation of the SCN entrain circadian rhythms. PLoS One (2013) 0.83
Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data. Ann Neurol (2002) 0.83
Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia. Neuropsychopharmacology (2011) 0.81
Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens. Eur J Neurosci (2002) 0.80
Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance. Eur J Neurosci (2005) 0.80
Assessment of sustained and divided attention in rats. Curr Protoc Neurosci (2003) 0.79
Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Biochem Pharmacol (2013) 0.79
Visceral afferent bias on cortical processing: role of adrenergic afferents to the basal forebrain cholinergic system. Behav Neurosci (2004) 0.77
Operant task performance and corticosterone concentrations in rats housed directly on bedding and on wire. J Am Assoc Lab Anim Sci (2008) 0.76
Author response. Neurology (2014) 0.75
What is in store for EJN? Eur J Neurosci (2008) 0.75
Why would you pay to get published? Eur J Neurosci (2011) 0.75
Early brain repair and protection. Eur J Neurosci (2012) 0.75
Repeated massage-like stimulation induces long-term effects on nociception: contribution of oxytocinergic mechanisms. Eur J Neurosci (2009) 0.75
Editorial. Eur J Neurosci (2010) 0.75